Evidence map›Paper›PMID 37483636›Full record

ArticleFrontiers in immunology2023

E protein binding at the

Ariana Mihai, Sumedha Roy, Michael S Krangel, Yuan Zhuang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ariana MihaiDepartment of Immunology, Duke University School of Medicine, Durham, NC, United States.
Sumedha RoyDepartment of Immunology, Duke University School of Medicine, Durham, NC, United States.
Michael S KrangelDepartment of Immunology, Duke University School of Medicine, Durham, NC, United States.
Yuan ZhuangDepartment of Immunology, Duke University School of Medicine, Durham, NC, United States.
Duke University · US

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI Maria Ciofani · 2014 to 2026
$26.3M
HEB MEDIATED PATHWAYS AND FUNCTION IN T CELL DEVELOPMENTR01GM059638 · NIGMS · DUKE UNIVERSITY · PI CHAN, FRANCIS KAMING · 1999 to 2021
$6.9M
Chromatin regulation of TCR locus V(D)J recombinationR35GM136284 · NIGMS · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2020 to 2024
$2.4M
NIAID NIH HHS P01 AI102853NIGMS NIH HHS R01 GM059638NIGMS NIH HHS R35 GM136284
6 · The paper itself

Abstract

V(D)J recombination of antigen receptor loci is a highly developmentally regulated process. During T lymphocyte development, recombination of the

Indexed as

Receptors, Antigen, T-Cell, alpha-betaThymocytesEnhancer Elements, GeneticProtein BindingTranscription FactorsV(D)J RecombinationReceptors, Antigen, T-Cell, alpha-betaTranscription FactorsE proteinsT cellsTcra enhancerThymusV(D)J recombination

Identifiers

PMID37483636
PMCPMC10358851
OpenAlexW4383373390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.